Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione

Star0

DB01496ExperimentalIllicitSmall molecule

Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione: Overview.

Mechanism: Pharmacologically active on Gamma-aminobutyric acid receptor subunit alpha-1, Gamma-aminobutyric acid receptor subunit alpha-2, and Gamma-aminobutyric acid receptor subunit alpha-3
Curator reviewed
Formula / weight: C₁₆H₁₁F₃N₂O₃S · 368.33 g/mol (avg)

Resolves to

Compound

UNIIR1JI58032BCAS959343-20-5PubChem3003157

Structure

InChIKeyDNZPLHRZXUJATK-UHFFFAOYSA-NSMILESFC(F)(F)C1=CC=CC=C1C1=CC=C(CC2C(=O)NC(=S)NC2=O)O1

Targets

P14867GABRA1P47869GABRA2P34903GABRA3P48169GABRA4P31644GABRA5Q16445GABRA6P36544CHRNA7P43681CHRNA4+2 more

What you can answer from here — as of August 31, 2026

10Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

366Drug interactionsStructured to mechanism, not free text

25+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account